Table 1 Characteristics and type of vaccine for COVID-19 administered to health care practitioners (HCPs) and patients with hematological malignancies.
Characteristics | HCP (N = 102) | Patients (N = 83) |
|---|---|---|
Age, median (range), years | 55 (50–69) | 55 (21–85) |
Male, no. (%) | 10 (10%) | 45 (54%) |
Comorbidities, no. (%) | ||
Any | 25 (24.5%) | 21 (25%) |
Body mass index > 30 | 11 (11%) | 13 (16%) |
Diabetes | 0 (0%) | 7 (8%) |
Hypertension | 8 (8%) | 11 (13%) |
Autoimmune disease | 7 (7%) | 3 (4%) |
Hematological malignancy, no. (%) | ||
B-cell lymphoproliferative disorders | - | 48 (58%) |
Monoclonal gammopathies | - | 28 (34%) |
Hodgkin lymphoma | - | 7 (8%) |
Type of vaccine, no. (%) | ||
BNT162b2 | 28 (27.4%) | 49 (59.0%) |
mRNA-1273 | 67 (65.7%) | 33 (39.8%) |
ChAdOx1 | 7 (6.9%) | 1 (1.2%) |
